Hair Loss and Irregular Menstrual Periods in a 16-Year-Old Female
The most likely diagnosis is polycystic ovary syndrome (PCOS), which should be evaluated with specific hormonal testing and pelvic ultrasound, followed by targeted treatment based on the patient's symptoms and metabolic profile. 1, 2
Initial Diagnostic Approach
Essential History Elements
- Menstrual pattern details: Document cycle length (normal is 21-45 days in adolescents), duration of irregularity, and whether cycles exceed 35 days more than twice yearly 2, 3
- Weight changes and BMI: Obesity strongly correlates with PCOS and menstrual irregularities 1
- Signs of hyperandrogenism: Ask specifically about acne, excessive facial/body hair (hirsutism), and scalp hair thinning pattern 1, 4
- Eating patterns and exercise habits: Screen for disordered eating, excessive exercise, and stress—common causes of functional hypothalamic amenorrhea 2, 3
- Medication use: Document any antiepileptic drugs (especially valproate), antipsychotics, or hormonal contraceptives 1, 2
Physical Examination Priorities
- Calculate BMI and waist-to-hip ratio: BMI >25 with truncal obesity (WHR >0.9) suggests PCOS 1
- Assess for hyperandrogenism: Examine for hirsutism using Ferriman-Gallwey scoring, acne distribution, and male-pattern hair loss 1, 4
- Evaluate hair loss pattern: Female pattern hair loss typically shows diffuse crown thinning with frontal hairline preservation (Ludwig pattern) or "Christmas tree pattern" 4
- Check for galactorrhea: Nipple discharge suggests hyperprolactinemia 1, 3
Laboratory Testing Algorithm
First-Line Tests (Mandatory)
- Pregnancy test: Must be performed first to exclude pregnancy 2, 3
- Hormonal panel on cycle days 3-6 (or randomly if amenorrheic): 1, 2
- FSH and LH (LH/FSH ratio >2 suggests PCOS)
- Testosterone (>2.5 nmol/L abnormal)
- Prolactin (>20 μg/L abnormal; rule out pituitary tumor)
- TSH (to exclude thyroid dysfunction)
- Mid-luteal progesterone (day 21 of cycle): <6 nmol/L indicates anovulation, common in PCOS 1
Second-Line Tests (Based on Initial Results)
- If PCOS suspected (irregular cycles + hyperandrogenism): 1
- Androstenedione (>10.0 nmol/L warrants tumor workup)
- DHEAS (elevated suggests adrenal hyperplasia)
- Fasting glucose and insulin (glucose/insulin ratio >4 suggests insulin resistance)
- Free androgen index (FAI)
Critical finding: Symptomatic adolescent girls show significantly higher testosterone and FAI levels compared to those with regular cycles, even with comparable BMI 5
Imaging Studies
- Pelvic ultrasound (transvaginal preferred if sexually active, transabdominal otherwise): 1, 2
- Perform on cycle days 3-9
- PCOS criteria: >10 peripheral cysts (2-8 mm diameter) in one plane with thickened ovarian stroma
- Assess endometrial thickness (<5 mm suggests estrogen deficiency; >8 mm suggests chronic anovulation)
Most Likely Diagnosis: PCOS
PCOS affects 4-6% of the general population but is the most common cause of irregular periods and hyperandrogenic hair loss in adolescents. 1, 4 The combination of oligomenorrhea (cycles >35 days) and hair loss in a 16-year-old strongly suggests this diagnosis.
Key Pathophysiology
PCOS involves accelerated GnRH secretion, insulin resistance, hyperinsulinemia, LH hypersecretion, and FSH hypofunction, resulting in hyperandrogenism, follicular arrest, and anovulation 1
PCOS Diagnostic Criteria (Modified for Adolescents)
- Oligomenorrhea or amenorrhea (>35 day cycles or <8 cycles/year) 1, 2
- Clinical or biochemical hyperandrogenism (hirsutism, acne, elevated testosterone) 1
- Polycystic ovaries on ultrasound 1
Important caveat: Isolated polycystic ovaries without symptoms occur in 17-22% of normal women and should not be confused with PCOS 1
Differential Diagnoses to Exclude
Functional Hypothalamic Amenorrhea (FHA)
- Accounts for 20-35% of secondary amenorrhea 3
- Associated with low body weight, excessive exercise, stress, or eating disorders 2, 3
- Laboratory findings: Low LH (<7 IU/ml), low estradiol, normal FSH, negative progesterone challenge 1, 2
- Red flags: Significant weight loss, BMI <18.5, signs of eating disorder 3
Hyperprolactinemia
- Accounts for ~20% of secondary amenorrhea 3
- Presents with galactorrhea, irregular cycles 1, 3
- Prolactin >20 μg/L (rule out hypothyroidism, pituitary tumor, medication effects) 1
Thyroid Dysfunction
Primary Ovarian Insufficiency (POI)
- Rare in adolescents unless history of chemotherapy/radiation 1
- FSH >40 mIU/mL on two occasions 4 weeks apart confirms diagnosis 2, 3
Hair Loss-Specific Differentials
- Telogen effluvium: Diffuse shedding 2-3 months after stressor; self-limited 6
- Alopecia areata: Focal patches with exclamation mark hairs; autoimmune 1
- Chronic telogen effluvium: Persistent diffuse thinning without clear trigger 4, 6
Treatment Approach for PCOS
First-Line Management
- Lifestyle modification: Weight loss of 5-10% significantly improves hormonal profile and menstrual regularity in overweight patients 1, 5
- Topical minoxidil 2%: Apply 1 mL twice daily for minimum 12 months for hair loss 4
- Only FDA-approved treatment for female pattern hair loss
- Expect 3-6 months before visible improvement
Hormonal Management
- Combined oral contraceptives: Regulate cycles, reduce androgens, improve hirsutism and acne 1
- Metformin: Consider if insulin resistance present (glucose/insulin ratio >4) 1
- Antiandrogens (spironolactone): Off-label for hirsutism and hair loss in severe cases 4
When to Refer
- Endocrinology referral if: 2, 3
- Significantly elevated androgens (testosterone >2.5 nmol/L, androstenedione >10.0 nmol/L)
- Suspected adrenal or ovarian tumor
- Persistent amenorrhea despite treatment
- Signs of Cushing syndrome or other endocrinopathy
- Gynecology referral if: 2, 3
- Primary amenorrhea by age 16
- Structural abnormalities on ultrasound
- Desire for fertility assessment
Critical Red Flags Requiring Urgent Evaluation
- Rapid, severe weight loss or BMI <17: Evaluate for eating disorder, consider hospitalization if vital signs unstable 1, 3
- Galactorrhea with headaches or visual changes: Urgent MRI to rule out pituitary tumor 1, 3
- Virilization (clitoromegaly, voice deepening): Suggests androgen-secreting tumor 1
- FSH >40 mIU/mL: Confirms POI; requires karyotype and specialist referral 1, 2
Long-Term Monitoring
- Bone density assessment: DXA scan if amenorrhea >6 months due to estrogen deficiency risk 3
- Metabolic screening: Annual fasting glucose and lipid panel in PCOS patients due to increased diabetes and cardiovascular risk 1, 5
- Psychological support: Screen for anxiety and depression, which are common with visible hair loss and body image concerns 1
The association between menstrual disorders, hyperandrogenism, obesity, and metabolic risks is already evident in adolescence, making early recognition and treatment essential. 5